Boston Business Journal |
Flagship Ventures startup aims for FDA, EU approval of painless blood collection device by this summer
FierceMedicalDevices (press release) (registration) The pivotal registration trial for the TAP Touch Activated Phlebotomy device is expected to support regulatory submissions in the U.S. and EU later this quarter. The Medford, MA-based startup anticipates speedy FDA and CE mark approvals--by later this ... Seventh Sense aims to upend blood testing as Theranos struggles Seventh Sense Biosystems Launches Pivotal Trial For Groundbreaking TAP Diagnostic Blood Collection Device |
from phlebotomy - Google News http://bit.ly/1oZ223y
No comments:
Post a Comment